UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045497
Receipt number R000051640
Scientific Title Early Chronic Pancreatitis Findings on EUS are Associated with Pancreatic Fibrosis, Chronic Inflammation, and Atrophy
Date of disclosure of the study information 2021/09/16
Last modified on 2021/11/16 09:04:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Early Chronic Pancreatitis Findings on EUS are Associated with Pancreatic Fibrosis, Chronic Inflammation, and Atrophy

Acronym

EUS findings of Early CP and Histology

Scientific Title

Early Chronic Pancreatitis Findings on EUS are Associated with Pancreatic Fibrosis, Chronic Inflammation, and Atrophy

Scientific Title:Acronym

EUS findings of Early CP and Histology

Region

Japan


Condition

Condition

intraductal papillary mucinous neoplasm, pancreatic neuroendocrine neoplasm, pancreatic ductal carcinoma in body/tail of the pancreas, and distal cholangiocarcinoma

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study aims to elucidate the associations of between EUS findings of early CP and histology.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Our primary hypothesis testing evaluated the statistical association between EUS findings (hyperechoic foci/stranding or lobularity) and histology (pancreatic fibrosis, inflammation, or atrophy).

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1) Patients aged over 20 years
2)The clinical data of 221 patients with pancreatic tumor or distal cholangiocarcinoma who underwent preoperative EUS and pancreatic surgery from January 2010 to November 2020 were collected.

Key exclusion criteria

1)Patients who have requested not to participate in this study based on public information.
2) Patients whose pathology specimens do not contain evaluable pancreatic tissue.
3) Patients deemed inappropriate by the principal investigator.

Target sample size

221


Research contact person

Name of lead principal investigator

1st name Atsuhiro
Middle name
Last name Masuda

Organization

Kobe University Graduate School of Medicine

Division name

Gastroenterology

Zip code

650-0017

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo

TEL

0783826305

Email

atmasuda@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Noriko
Middle name
Last name Inomata

Organization

Kobe University Graduate School of Medicine

Division name

Gastroenterology

Zip code

650-0017

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo

TEL

0783826305

Homepage URL


Email

inomat@med.kobe-u.ac.jp


Sponsor or person

Institute

Division of Gastroenterology, Department of Internal Medicine
Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Division of Gastroenterology, Department of Internal Medicine
Kobe University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Division of Gastroenterology, Department of Internal Medicine Kobe University Graduate School of Medicine

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo

Tel

0783826305

Email

rinri@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

221

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 09 Month 01 Day

Date of IRB

2021 Year 09 Month 22 Day

Anticipated trial start date

2021 Year 10 Month 01 Day

Last follow-up date

2021 Year 11 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Clinical information included age, sex, BMI, diabetes mellitus, alcohol consumption, and smoking status (never, former, or current).
Early CP EUS indings and histology of background pancreas were also collected.


Management information

Registered date

2021 Year 09 Month 16 Day

Last modified on

2021 Year 11 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051640


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name